Download Files:
Products Details
Product Description
– Imvotamab (IGM-2323), a CD20xCD3 bispecific IGM antibody featuring a dual-action mechanism, promotes physiological T cell activation to avoid both over-stimulation and immune function down-regulation. This compound is under development for addressing B-cell malignant tumors, including multiple myeloma (MM) and non-Hodgkin’s lymphoma (NHL) [1] [2] [3] [4].
Web ID
– T77033
Storage Temperature
– -20℃
Shipping
– Blue Ice
CAS Number
– 2573121-53-4
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
Anti-SARS-CoV-2 Spike mAb (CR3022)
835 CAD – 1,389 CADPrice range: 835 CAD through 1,389 CAD
1000 in stock
1000 in stock
1000 in stock
1000 in stock